As of Jul 29
| +2.09 / +2.37%|
The 15 analysts offering 12-month price forecasts for Incyte Corp have a median target of 93.00, with a high estimate of 105.00 and a low estimate of 76.00. The median estimate represents a +3.09% increase from the last price of 90.21.
The current consensus among 18 polled investment analysts is to Buy stock in Incyte Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.